Hypercoagulability as a Paraneoplastic Syndrome
Über den Vortrag
Der Vortrag „Hypercoagulability as a Paraneoplastic Syndrome“ von Richard Mitchell, MD, PhD ist Bestandteil des Kurses „NCM 112 Care of Clients with Problems in Oxygenation, Fluid and Electrolytes, Inflammatory and Immunologic Response, and Cellular Aberrations (Philippines Nursing Curriculum)“.
Quiz zum Vortrag
Which inflammatory-mediated molecules cause hypercoagulability in patients with cancer?
- Factor VIII and fibrinogen
- Hepcidin and fibrinogen
- Ceruloplasmin and hepcidin
- CRP and ferritin
- Transferrin and haptoglobin
Which statement is correct relative to cancer and hypercoagulability?
- Extrinsic vascular compression by a tumor increases the risk of thrombosis.
- Decreased tissue factor production by tumor and endothelial cells.
- Decreased platelet activation and accumulation
- Decreased expression of phosphatidylserine by tumor cells
- Elevated levels of protein C and S in serum
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Hypercoagulability as a Paraneoplastic Syndrome
Richard Mitchell, MD, PhD
Dr. Richard N. Mitchell is the Lawrence J. Henderson Professor of Pathology and Health Sciences and Technology, at Harvard Medical School in Massachusetts, USA.
He obtained his PhD in Cell Biology and Immunology from Rockefeller University in 1980, and his MD from Harvard Medical School in 1984. Currently, he is Program Director of the Health Sciences and Technology Education and Curriculum at Harvard Medical School.
Due to his achievements, he earned the ASIP Robbins Distinguished Educator Award in 2013.
Within Lecturio, Dr. Mitchell teaches courses on Pathology.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
